Forskning ved Københavns Universitet - Københavns Universitet

Forside

S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases?

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases? / Schneider, M.; Sheikh, S.P.; Hansen, Jakob Lerche.

I: Journal of Molecular Medicine, Bind 86, Nr. 5, 2008, s. 507-522.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Schneider, M, Sheikh, SP & Hansen, JL 2008, 'S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases?', Journal of Molecular Medicine, bind 86, nr. 5, s. 507-522.

APA

Schneider, M., Sheikh, S. P., & Hansen, J. L. (2008). S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases? Journal of Molecular Medicine, 86(5), 507-522.

Vancouver

Schneider M, Sheikh SP, Hansen JL. S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases? Journal of Molecular Medicine. 2008;86(5):507-522.

Author

Schneider, M. ; Sheikh, S.P. ; Hansen, Jakob Lerche. / S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases?. I: Journal of Molecular Medicine. 2008 ; Bind 86, Nr. 5. s. 507-522.

Bibtex

@article{c414f8509c5711debc73000ea68e967b,
title = "S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases?",
abstract = "Multiple reports have focused on S100A4's role in cancer progression, specifically its ability to enhance metastasis. However, recent studies have linked S100A4 to several diseases besides cancer, including kidney fibrosis, cirrhosis, pulmonary disease, cardiac hypertrophy and fibrosis, arthritis and neuronal injuries. Common to all these diseases is the involvement of fibrotic and inflammatory processes, i.e. processes greatly dependent on tissue remodelling, cell motility and epithelial-mesenchymal transition. Therefore, the basic biological mechanisms behind S100A4's effects are emerging. S100A4 belongs to the S100 family of proteins that contain two Ca2+-binding sites including a canonical EF-hand motif. S100A4 is involved in the regulation of a wide range of biological effects including cell motility, survival, differentiation and contractility. S100A4 has both intracellular and extracellular effects. Hence, S100A4 interacts with cytoskeletal proteins and enhances metastasis of several types of cancer cells. In addition, S100A4 is secreted by unknown mechanisms, thus, paracrinely stimulating a variety of cellular responses, including angiogenesis and neuronal growth. Although many cellular effects of S100A4 are well described, the molecular mechanisms whereby S100A4 elicits these responses remain largely unknown. However, it is likely that the intracellular and the extracellular effects involve distinct mechanisms. In this review, we explore the possible roles of S100A4 in non-cancer diseases and employ this knowledge to describe underlying biological mechanisms including a change in cellular phenotype towards less tightly adherent cells and activation of fibrotic processes that may explain this protein's involvement in multiple pathologies Udgivelsesdato: 2008/5",
author = "M. Schneider and S.P. Sheikh and Hansen, {Jakob Lerche}",
year = "2008",
language = "English",
volume = "86",
pages = "507--522",
journal = "Journal of Molecular Medicine",
issn = "0946-2716",
publisher = "Springer",
number = "5",

}

RIS

TY - JOUR

T1 - S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases?

AU - Schneider, M.

AU - Sheikh, S.P.

AU - Hansen, Jakob Lerche

PY - 2008

Y1 - 2008

N2 - Multiple reports have focused on S100A4's role in cancer progression, specifically its ability to enhance metastasis. However, recent studies have linked S100A4 to several diseases besides cancer, including kidney fibrosis, cirrhosis, pulmonary disease, cardiac hypertrophy and fibrosis, arthritis and neuronal injuries. Common to all these diseases is the involvement of fibrotic and inflammatory processes, i.e. processes greatly dependent on tissue remodelling, cell motility and epithelial-mesenchymal transition. Therefore, the basic biological mechanisms behind S100A4's effects are emerging. S100A4 belongs to the S100 family of proteins that contain two Ca2+-binding sites including a canonical EF-hand motif. S100A4 is involved in the regulation of a wide range of biological effects including cell motility, survival, differentiation and contractility. S100A4 has both intracellular and extracellular effects. Hence, S100A4 interacts with cytoskeletal proteins and enhances metastasis of several types of cancer cells. In addition, S100A4 is secreted by unknown mechanisms, thus, paracrinely stimulating a variety of cellular responses, including angiogenesis and neuronal growth. Although many cellular effects of S100A4 are well described, the molecular mechanisms whereby S100A4 elicits these responses remain largely unknown. However, it is likely that the intracellular and the extracellular effects involve distinct mechanisms. In this review, we explore the possible roles of S100A4 in non-cancer diseases and employ this knowledge to describe underlying biological mechanisms including a change in cellular phenotype towards less tightly adherent cells and activation of fibrotic processes that may explain this protein's involvement in multiple pathologies Udgivelsesdato: 2008/5

AB - Multiple reports have focused on S100A4's role in cancer progression, specifically its ability to enhance metastasis. However, recent studies have linked S100A4 to several diseases besides cancer, including kidney fibrosis, cirrhosis, pulmonary disease, cardiac hypertrophy and fibrosis, arthritis and neuronal injuries. Common to all these diseases is the involvement of fibrotic and inflammatory processes, i.e. processes greatly dependent on tissue remodelling, cell motility and epithelial-mesenchymal transition. Therefore, the basic biological mechanisms behind S100A4's effects are emerging. S100A4 belongs to the S100 family of proteins that contain two Ca2+-binding sites including a canonical EF-hand motif. S100A4 is involved in the regulation of a wide range of biological effects including cell motility, survival, differentiation and contractility. S100A4 has both intracellular and extracellular effects. Hence, S100A4 interacts with cytoskeletal proteins and enhances metastasis of several types of cancer cells. In addition, S100A4 is secreted by unknown mechanisms, thus, paracrinely stimulating a variety of cellular responses, including angiogenesis and neuronal growth. Although many cellular effects of S100A4 are well described, the molecular mechanisms whereby S100A4 elicits these responses remain largely unknown. However, it is likely that the intracellular and the extracellular effects involve distinct mechanisms. In this review, we explore the possible roles of S100A4 in non-cancer diseases and employ this knowledge to describe underlying biological mechanisms including a change in cellular phenotype towards less tightly adherent cells and activation of fibrotic processes that may explain this protein's involvement in multiple pathologies Udgivelsesdato: 2008/5

M3 - Journal article

VL - 86

SP - 507

EP - 522

JO - Journal of Molecular Medicine

JF - Journal of Molecular Medicine

SN - 0946-2716

IS - 5

ER -

ID: 14276353